SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-021000
Filing Date
2022-08-02
Accepted
2022-08-02 16:07:59
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3652
  Complete submission text file 0001493152-22-021000.txt   5092
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Issuer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4177 ROCKRIDGE ROAD WEST VANCOUVER A1 V7W 1A3
Business Address
Lustig Marc (Reporting) CIK: 0001940908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40101 | Film No.: 221128722